{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:06:06Z","timestamp":1758931566617,"version":"3.44.0"},"reference-count":65,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,12]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease is a neurological disease with a rising incidence and prevalence. Patients with Parkinson\u2019s disease may receive antipsychotics, for example, due to Parkinson\u2019s disease psychosis. Parkinson\u2019s disease psychosis is characterised by visual hallucinations and other psychotic symptoms. To date, no systematic review has evaluated the effects of antipsychotics in patients with Parkinson\u2019s disease. Therefore, this review aims to assess the beneficial and harmful effects of antipsychotics for Parkinson\u2019s disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is a protocol for a systematic review. A search specialist will perform a search in major medical databases (eg, MEDLINE (Medical Literature Analysis and Retrieval System Online), EMBASE (Excerpta Medica database), CENTRAL (Cochrane Central Register of Controlled Trials)) and clinical trial registries. Published and unpublished randomised clinical trials comparing antipsychotics to any control (placebo, standard care or other antipsychotics) in patients with Parkinson\u2019s disease will be included. Two review authors will independently extract data and conduct risk of bias assessments with the Cochrane Risk of Bias tool\u2014V.2. Primary outcomes will be all-cause mortality, serious adverse events and significant falls. Secondary outcomes will be hospitalisations, non-serious adverse events, Unified Parkinson\u2019s Disease Rating Scale total score and psychotic symptoms using any valid symptom scale. Data will be synthesised by aggregate meta-analysis, trial sequential analysis and network meta-analysis. Several subgroup analyses are planned. An eight-step procedure will be used to assess if the thresholds for clinical significance are crossed, and the certainty of the evidence will be assessed by GRADE (Grading of Recommendations Assessment, Development and Evaluations) and CiNeMA (Confidence in Network Meta-Analysis) approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>This protocol does not include results, and ethics approval is not required for the project. The findings from the systematic review will be published in international peer-reviewed scientific journals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>PROSPERO ID: CRD42025633985. Available from <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42025633985\">https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42025633985<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-098931","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:00:18Z","timestamp":1758877218000},"page":"e098931","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotics for Parkinson\u2019s disease: a protocol for a systematic review with network meta-analysis and trial sequential analysis"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-1958","authenticated-orcid":false,"given":"Johanne Juul","family":"Petersen","sequence":"first","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"},{"name":"University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Barkholt","family":"Kamp","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-2904","authenticated-orcid":false,"given":"Sophie","family":"Juul","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"},{"name":"Department of Psychology, University of Copenhagen, Copenhagen, Denmark"},{"name":"Capital Region of Denmark Mental Health Services, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2224-9189","authenticated-orcid":false,"given":"Jonas Leth","family":"Bjerg","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9247-5245","authenticated-orcid":false,"given":"Christina Dam Bjerregaard","family":"Sillassen","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"},{"name":"Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-2070","authenticated-orcid":false,"given":"Pascal","family":"Faltermeier","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisette","family":"Salvesen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen NV, Denmark"},{"name":"University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mette","family":"Hejl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bech","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7543-6031","authenticated-orcid":false,"given":"Annemette","family":"L\u00f8kkegaard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen NV, Denmark"},{"name":"University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Rigshospitalet Copenhagen Trial Unit, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2025092602001177000_15.9.e098931.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"2025092602001177000_15.9.e098931.2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"The Lancet"},{"key":"2025092602001177000_15.9.e098931.3","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13691"},{"key":"2025092602001177000_15.9.e098931.4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee","volume":"97","author":"Pringsheim","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025092602001177000_15.9.e098931.5","doi-asserted-by":"crossref","unstructured":"Petersen JJ , Kamp CB , Faltermeier P , et al . Deep brain stimulation for Parkinson\u2019s disease: systematic review with meta-analysis and trial sequential analysis. BMJ Medicine 2024;3. doi:10.1136\/bmjmed-2023-000705","DOI":"10.1136\/bmjmed-2023-000705"},{"key":"2025092602001177000_15.9.e098931.6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s13311-020-00939-x","article-title":"Surgical Treatment of Parkinson\u2019s Disease: Devices and Lesion Approaches","volume":"17","author":"Sharma","year":"2020","journal-title":"Neurotherapeutics"},{"key":"2025092602001177000_15.9.e098931.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.014"},{"key":"2025092602001177000_15.9.e098931.8","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0416-8"},{"key":"2025092602001177000_15.9.e098931.9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21382"},{"key":"2025092602001177000_15.9.e098931.10","doi-asserted-by":"crossref","first-page":"106004","DOI":"10.1016\/j.parkreldis.2024.106004","article-title":"Real or imagined: We need a new scale for psychosis in Parkinson\u2019s disease","volume":"121","author":"Pontone","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"2025092602001177000_15.9.e098931.11","article-title":"Management of Psychosis in Parkinson\u2019s Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition","volume":"2017","author":"Taddei","year":"2017","journal-title":"Parkinsons Dis"},{"key":"2025092602001177000_15.9.e098931.12","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.139"},{"key":"2025092602001177000_15.9.e098931.13","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/RMHP.S313212","article-title":"Trends and Contributing Factors for Prescribing Antipsychotics in Newly Diagnosed Parkinson\u2019s Disease Patients: A Population-Based Study","volume":"14","author":"Orayj","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"2025092602001177000_15.9.e098931.14","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4938154","article-title":"The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson\u2019s Disease","volume":"2016","author":"Divac","year":"2016","journal-title":"Behav Neurol"},{"key":"2025092602001177000_15.9.e098931.15","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S117321"},{"key":"2025092602001177000_15.9.e098931.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2024.02.008"},{"key":"2025092602001177000_15.9.e098931.17","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S201029"},{"key":"2025092602001177000_15.9.e098931.18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjpo.bp.115.000927","article-title":"Antipsychotics for the management of psychosis in Parkinson\u2019s disease: systematic review and meta-analysis","volume":"1","author":"Jethwa","year":"2015","journal-title":"BJPsych Open"},{"key":"2025092602001177000_15.9.e098931.19","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1192\/bjo.2024.701","article-title":"Systematic Literature Review and Meta-Analysis of Anti-Psychotic Use in Parkinson\u2019s Disease Psychosis","volume":"10","author":"McKeown","year":"2024","journal-title":"BJPsych Open"},{"key":"2025092602001177000_15.9.e098931.20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/08919887231154933","article-title":"Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson\u2019s Disease Psychosis: Systematic Review and Network Meta-Analysis","volume":"36","author":"Yunusa","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2025092602001177000_15.9.e098931.21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2020.07.021","article-title":"Efficacy and safety of atypical antipsychotics for psychosis in Parkinson\u2019s disease: A systematic review and Bayesian network meta-analysis","volume":"78","author":"Iketani","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"2025092602001177000_15.9.e098931.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100993","article-title":"Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialities","volume":"43","author":"Juul","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2025092602001177000_15.9.e098931.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.q2280","article-title":"We need to rethink outcomes in Parkinson\u2019s disease research","volume":"387","author":"Petersen","year":"2024","journal-title":"BMJ"},{"key":"2025092602001177000_15.9.e098931.24","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2025092602001177000_15.9.e098931.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025092602001177000_15.9.e098931.26","unstructured":"ICH harmonised guideline: integrated addemdum to ich e6(r1): guideline for good clinical practice (ich-gcp. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2015 Available: https:\/\/ichgcp.net\/da"},{"key":"2025092602001177000_15.9.e098931.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i65","article-title":"Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports","volume":"352","author":"Sharma","year":"2016","journal-title":"BMJ"},{"key":"2025092602001177000_15.9.e098931.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002101","article-title":"Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis","volume":"13","author":"Schroll","year":"2016","journal-title":"PLoS Med"},{"key":"2025092602001177000_15.9.e098931.29","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-019-0983-y","article-title":"Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports","volume":"9","author":"J\u00f8rgensen","year":"2020","journal-title":"Syst Rev"},{"key":"2025092602001177000_15.9.e098931.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111470"},{"key":"2025092602001177000_15.9.e098931.31","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-018-0766-x","article-title":"The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors","volume":"7","author":"Hodkinson","year":"2018","journal-title":"Syst Rev"},{"key":"2025092602001177000_15.9.e098931.32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1353\/pbm.2019.0009","article-title":"Exploring the Asymmetrical Relationship Between the Power of Finance Bias and Evidence","volume":"62","author":"Howick","year":"2019","journal-title":"Perspect Biol Med"},{"key":"2025092602001177000_15.9.e098931.33","unstructured":"StataCorp . Stata Statistical Software: Release 18; College Station, TX StataCorp LLC; 2023. Available: http:\/\/www.stata.com"},{"key":"2025092602001177000_15.9.e098931.34","unstructured":"Thorlund K , Engstr\u00f8m J , Wetterslev J , et al . Copenhagen trial unit [TSA - trial sequential analysis]. n.d. Available: http:\/\/www.ctu.dk\/tsa"},{"key":"2025092602001177000_15.9.e098931.35","unstructured":"Thorlund K , Engstr\u00f8m JW , J\u00f8rn Brok J , et al . User manual for trial sequential analysis (tsa). Copenhagen, Denmark Copenhagen Trial Unit, Centre for Clinical Intervention Research. Available: http:\/\/www.ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"2025092602001177000_15.9.e098931.36","article-title":"Industry sponsorship and research outcome","volume":"12","author":"Lundh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025092602001177000_15.9.e098931.37","unstructured":"Higgins J , Thomas J , Chandler J , et al . Cochrane Handbook for Systematic Reviews of Interventions. Cochrane, 2023. Available: www.training.cochrane.org\/handbook"},{"key":"2025092602001177000_15.9.e098931.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025092602001177000_15.9.e098931.39","unstructured":"Higgins J , Thomas J , Chandler J , et al . Cochrane, 2021. Available: www.training.cochrane.org\/handbook"},{"key":"2025092602001177000_15.9.e098931.40","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"2025092602001177000_15.9.e098931.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025092602001177000_15.9.e098931.42","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2380"},{"key":"2025092602001177000_15.9.e098931.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025092602001177000_15.9.e098931.44","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"2025092602001177000_15.9.e098931.45","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.140"},{"key":"2025092602001177000_15.9.e098931.46","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-10-90","article-title":"Evidence at a glance: error matrix approach for overviewing available evidence","volume":"10","author":"Keus","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"2025092602001177000_15.9.e098931.47","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025092602001177000_15.9.e098931.48","first-page":"177","volume-title":"Meta-Analysis in Clinical Trials","volume":"7","author":"DerSimonian","year":"1986"},{"key":"2025092602001177000_15.9.e098931.49","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780060325"},{"key":"2025092602001177000_15.9.e098931.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.013"},{"key":"2025092602001177000_15.9.e098931.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.10.007"},{"key":"2025092602001177000_15.9.e098931.52","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn188"},{"key":"2025092602001177000_15.9.e098931.53","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn179"},{"key":"2025092602001177000_15.9.e098931.54","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"2025092602001177000_15.9.e098931.55","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s9242"},{"key":"2025092602001177000_15.9.e098931.56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"key":"2025092602001177000_15.9.e098931.57","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network Meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"The Stata Journal: Promoting communications on statistics and Stata"},{"key":"2025092602001177000_15.9.e098931.58","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"key":"2025092602001177000_15.9.e098931.59","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"2025092602001177000_15.9.e098931.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025092602001177000_15.9.e098931.61","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"2025092602001177000_15.9.e098931.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.02.016"},{"key":"2025092602001177000_15.9.e098931.63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025092602001177000_15.9.e098931.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011"},{"key":"2025092602001177000_15.9.e098931.65","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"Can Med Assoc J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-098931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:00:25Z","timestamp":1758877225000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-098931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,26]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2025-098931"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-098931","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}